Episode 11: Step Up Therapy In Asthma, A Therapy For Habit Cough

For today’s episode we will be reviewing three articles from the Jan-Feb 2020 issue of Allergy Watch, a bimonthly publication which provides research summaries to College members from the major journals in allergy and immunology. You can also earn CME credit by listening to this podcast! For information about CME credit, head over to https://college.acaai.org/allergytalk Article links: Loss of bronchoprotection with ICS plus LABA treatment, β-receptor dynamics, and the effect of alendronate. Step-Up Therapy in Black Children and Adults with Poorly Controlled Asthma. Unexpected and unintended cure of habit cough by proxy. Please rate our podcast on iTunes! Please give us feedback, corrections, and suggestions! Email feedback to: [email protected] ACAAI is presenting this podcast for educational purposes only. It is not medical advice or intended to replace the judgment of a licensed physician. The College is not responsible for any claims related to procedures, professionals, products or methods discussed in the podcast, and it does not approve or endorse any products, professionals, services or methods that might be referenced. Today’s speakers have the following disclosures: Drs. Lee and Kalangara have nothing to disclose. Dr. Fineman Speaker: AstraZenca, Boehringer Ingelheim, Shire; Research: Aimmune, DBV, Shire, Regeneron.